Prospective evaluation of type 2 diabetes mellitus on the risk of primary liver cancer in chinese men and women

Annals of Oncology

Volumn 24, Issue 6, 2013, Pages 1679-1685

  Yang, W S ^a,b   Shu, X O ^c   Gao J , ^b   Li, H L ^b   Cai, H ^c   Yang, G ^c   Ji, B T ^d   Rothman, N ^d   Gao, Y T ^b   Zheng, W ^c   Xiang, Y B ^b  

^a FUDAN UNIVERSITY   (China)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^c VANDERBILT INGRAM CANCER CENTER   (United States)

^d NATIONAL CANCER INSTITUTE   (United States)

Author keywords

China; Cohort study; Primary liver cancer; Type 2 diabetes

Indexed keywords

ADULT; AGED; ARTICLE; CANCER INCIDENCE; CANCER RISK; CHINESE; DISEASE ASSOCIATION; DISEASE DURATION; FEMALE; FOLLOW UP; HUMAN; HYPERGLYCEMIA; HYPERINSULINEMIA; LIVER CANCER; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE;

EID: 84878445348     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdt017     Document Type: Article

References (33)

1. Gao S, Yang WS, Bray F et al. Declining rates of hepatocellular carcinoma in urban Shanghai: incidence trends in 1976-2005. Eur J Epidemiol 2012; 27: 39-46.
2. Shen QJ, Zhang XF, Chen JG et al. [An age-period-cohort modelling study on primary liver cancer incidence rate in Qidong]. Zhonghua Liu Xing Bing Xue Za Zhi 2004; 25: 902-904.
3. Pan XR, Yang WY, Li GW et al. Prevalence of diabetes and its risk factors in China, 1994. National Diabetes Prevention and Control Cooperative Group. Diabetes Care 1997; 20: 1664-1669.
4. Yang W, Lu J, Weng J et al. Prevalence of diabetes among men and women in China. N Engl J Med 2010; 362: 1090-1101.
5. Hu FB. Globalization of diabetes: the role of diet, lifestyle, and genes. Diabetes Care 2011; 34: 1249-1257.
6. Normile D. Public health. A sense of crisis as China confronts ailments of affluence. Science 2010; 328: 422-424.
7. Yang WS, Va P, Bray F et al. The role of pre-existing diabetes mellitus on hepatocellular carcinoma occurrence and prognosis: a meta-analysis of prospective cohort studies. PLoS One 2011; 6: e27326.
8. Nicolucci A. Epidemiological aspects of neoplasms in diabetes. Acta Diabetol 2010; 47: 87-95.
9. Giovannucci E, Harlan DM, Archer MC et al. Diabetes and cancer: a consensus report. Diabetes Care 2010; 33: 1674-1685.
10. Shibata M, Kihara Y, Taguchi M et al. Nonalcoholic fatty liver disease is a risk factor for type 2 diabetes in middle-aged Japanese men. Diabetes Care 2007; 30: 2940-2944.
11. Johnson JA, Bowker SL, Richardson K et al. Time-varying incidence of cancer after the onset of type 2 diabetes: evidence of potential detection bias. Diabetologia 2011; 54: 2263-2271.
12. Villegas R, Yang G, Liu D et al. Validity and reproducibility of the food-frequency questionnaire used in the Shanghai men's health study. Br J Nutr 2007; 97: 993-1000.
13. Zheng W, Chow WH, Yang G et al. The Shanghai Women's Health Study: rationale, study design, and baseline characteristics. Am J Epidemiol 2005; 162: 1123-1131.
14. Lee MY, Lin KD, Hsiao PJ et al. The association of diabetes mellitus with liver, colon, lung, and prostate cancer is independent of hypertension, hyperlipidemia, and gout in Taiwanese patients. Metabolism 2012; 61: 242-249.
15. Lai SW, Chen PC, Liao KF et al. Risk of hepatocellular carcinoma in diabetic patients and risk reduction associated with anti-diabetic therapy: a population-based cohort study. Am J Gastroenterol 2012; 107: 46-52.
16. Chen CL, Yang HI, Yang WS et al. Metabolic factors and risk of hepatocellular carcinoma by chronic hepatitis B/C infection: a follow-up study in Taiwan. Gastroenterology 2008; 135: 111-121.
17. Wang CS, Yao WJ, Chang TT et al. The impact of type 2 diabetes on the development of hepatocellular carcinoma in different viral hepatitis statuses. Cancer Epidemiol Biomarkers Prev 2009; 18: 2054-2060.
18. Hassan MM, Hwang LY, Hatten CJ et al. Risk factors for hepatocellular carcinoma: synergism of alcohol with viral hepatitis and diabetes mellitus. Hepatology 2002; 36: 1206-1213.
19. Yuan JM, Govindarajan S, Arakawa K et al. Synergism of alcohol, diabetes, and viral hepatitis on the risk of hepatocellular carcinoma in blacks and whites in the US. Cancer 2004; 101: 1009-1017.
20. Veldt BJ, Chen W, Heathcote EJ et al. Increased risk of hepatocellular carcinoma among patients with hepatitis C cirrhosis and diabetes mellitus. Hepatology 2008; 47: 1856-1862.
21. Knowler WC, Barrett-Connor E, Fowler SE et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002; 346: 393-403.
22. Siegel LC, Sesso HD, Bowman TS et al. Physical activity, body mass index, and diabetes risk in men: a prospective study. Am J Med 2009; 122: 1115-1121.
23. Weinstein AR, Sesso HD, Lee IM et al. Relationship of physical activity vs body mass index with type 2 diabetes in women. JAMA 2004; 292: 1188-1194.
24. Calle EE, Rodriguez C, Walker-Thurmond K et al. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of US adults. N Engl J Med 2003; 348: 1625-1638.
25. Nair S, Mason A, Eason J et al. Is obesity an independent risk factor for hepatocellular carcinoma in cirrhosis? Hepatology 2002; 36: 150-155.
26. Yun YH, Lim MK, Won YJ et al. Dietary preference, physical activity, and cancer risk in men: national health insurance corporation study. BMC Cancer 2008; 8: 366.
27. Knowler WC, Fowler SE, Hamman RF et al. 10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study. Lancet 2009; 374: 1677-1686.
28. Saito K, Inoue S, Saito T et al. Augmentation effect of postprandial hyperinsulinaemia on growth of human hepatocellular carcinoma. Gut 2002; 51: 100-104.
29. Donadon V, Balbi M, Zanette G. Hyperinsulinemia and risk for hepatocellular carcinoma in patients with chronic liver diseases and Type 2 diabetes mellitus. Expert Rev Gastroenterol Hepatol 2009; 3: 465-467.
30. Giovannucci E. Nutrition, insulin, insulin-like growth factors and cancer. Horm Metab Res 2003; 35: 694-704.
31. Li R, Lu W, Jiang QW et al. Increasing prevalence of type 2 diabetes in chinese adults in shanghai. Diabetes Care 2012; 35: 1028-1030.
32. Martin LM, Leff M, Calonge N et al. Validation of self-reported chronic conditions and health services in a managed care population. Am J Prev Med 2000; 18: 215-218.
33. Wu SC, Li CY, Ke DS. The agreement between self-reporting and clinical diagnosis for selected medical conditions among the elderly in Taiwan. Public Health 2000; 114: 137-142.